|
gptkbp:instanceOf
|
gptkb:chemical_compound
vasoconstrictor
imidazoline derivative
|
|
gptkbp:ATCCode
|
S01GA03
|
|
gptkbp:brand
|
gptkb:Clear_Eyes
Naphcon
Privine
|
|
gptkbp:CASNumber
|
550-99-2
|
|
gptkbp:contraindication
|
narrow-angle glaucoma
hypersensitivity
|
|
gptkbp:discoveredIn
|
1942
|
|
gptkbp:drugClass
|
sympathomimetic
|
|
gptkbp:eliminationHalfLife
|
unknown
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:hasInChIKey
|
QTLUBYQIEMUBKX-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C14H14N2
|
|
gptkbp:hasSMILES
|
c1ccc2c(c1)cccc2CCN=C(N)N
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
naphazoline
|
|
gptkbp:legalStatus
|
OTC (in some countries)
|
|
gptkbp:mechanismOfAction
|
alpha-adrenergic agonist
|
|
gptkbp:meltingPoint
|
98–100 °C
|
|
gptkbp:metabolism
|
hepatic
|
|
gptkbp:molecularWeight
|
210.28 g/mol
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1201292
4285
4438
|
|
gptkbp:relatedTo
|
gptkb:tetrahydrozoline
oxymetazoline
xylometazoline
|
|
gptkbp:routeOfAdministration
|
topical
ophthalmic
|
|
gptkbp:sideEffect
|
rebound congestion
irritation
|
|
gptkbp:solubility
|
soluble in water
|
|
gptkbp:UNII
|
8P2208FRT8
|
|
gptkbp:usedFor
|
nasal congestion
ocular redness
|
|
gptkbp:bfsParent
|
gptkb:Visine
|
|
gptkbp:bfsLayer
|
7
|